UPDATE: Piper Sandler Downgrades Teva Pharma (TEVA) to Underweight
Tweet Send to a Friend
(Updated - May 4, 2022 6:21 AM EDT)
Piper Sandler analyst David Amsellem downgraded Teva Pharma (NYSE: TEVA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst David Amsellem downgraded Teva Pharma (NYSE: TEVA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
